What's more, it addresses the FDA’s communications Together with the applicant, the retention of data that support the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer ownership of an SE report back to a fresh applicant and Digital submission of your SE report and